- Home
- KRON vs ESLA Comparison
KRON vs ESLA Comparison
Compare KRON & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRON
- ESLA
- Stock Information
- Founded
- KRON 2017
- ESLA 2021
- Country
- KRON United States
- ESLA United States
- Employees
- KRON N/A
- ESLA N/A
- Industry
- KRON Medicinal Chemicals and Botanical Products
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KRON Health Care
- ESLA Health Care
- Exchange
- KRON Nasdaq
- ESLA Nasdaq
- Market Cap
- KRON 41.0M
- ESLA 35.5M
- IPO Year
- KRON 2020
- ESLA N/A
- Fundamental
- Price
- KRON $0.67
- ESLA $0.97
- Analyst Decision
- KRON Buy
- ESLA Strong Buy
- Analyst Count
- KRON 3
- ESLA 1
- Target Price
- KRON $1.63
- ESLA $16.00
- AVG Volume (30 Days)
- KRON 826.3K
- ESLA 23.1K
- Earning Date
- KRON 06-10-2025
- ESLA 05-14-2025
- Dividend Yield
- KRON N/A
- ESLA N/A
- EPS Growth
- KRON N/A
- ESLA N/A
- EPS
- KRON N/A
- ESLA N/A
- Revenue
- KRON $9,192,000.00
- ESLA N/A
- Revenue This Year
- KRON N/A
- ESLA $101.09
- Revenue Next Year
- KRON N/A
- ESLA N/A
- P/E Ratio
- KRON N/A
- ESLA N/A
- Revenue Growth
- KRON 21.16
- ESLA N/A
- 52 Week Low
- KRON $0.65
- ESLA $0.63
- 52 Week High
- KRON $1.60
- ESLA $3.23
- Technical
- Relative Strength Index (RSI)
- KRON 33.35
- ESLA 46.34
- Support Level
- KRON $0.66
- ESLA $0.97
- Resistance Level
- KRON $0.75
- ESLA $1.04
- Average True Range (ATR)
- KRON 0.03
- ESLA 0.06
- MACD
- KRON 0.00
- ESLA -0.01
- Stochastic Oscillator
- KRON 19.47
- ESLA 27.27
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.